HARBOURVEST PARTNERS LLC - Q3 2021 holdings

$1.06 Billion is the total value of HARBOURVEST PARTNERS LLC's 56 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
W  Wayfair, Inc.$271,384,000
-19.1%
1,062,1260.0%25.49%
-20.5%
BHG  Bright Health Group, Inc.$34,417,000
-52.4%
4,217,7150.0%3.23%
-53.3%
EVLO  Evelo Biosciences, Inc.$21,567,000
-48.8%
3,063,5050.0%2.03%
-49.7%
RUBY  Rubius Therapeutics, Inc.$17,645,000
-26.8%
986,8780.0%1.66%
-28.1%
FTCH  Farfetch Ltd.ordinary shares cla$16,593,000
-25.6%
442,7160.0%1.56%
-26.8%
WHD  Cactus, Inc.$14,820,000
+2.7%
392,8960.0%1.39%
+0.9%
LC  LendingClub Corp.$14,500,000
+55.8%
513,4400.0%1.36%
+53.0%
KLDO  Kaleido BioSciences, Inc.$10,013,000
-26.6%
1,833,8320.0%0.94%
-27.8%
RLAY  Relay Therapeutics, Inc.$9,346,000
-13.8%
296,4020.0%0.88%
-15.3%
AXLA  Axcella Health, Inc.$8,368,000
-25.7%
2,807,9810.0%0.79%
-27.0%
TWLO  Twilio, Inc.$4,649,000
-19.1%
14,5720.0%0.44%
-20.4%
SGTX  Sigilon Therapeutics, Inc.$4,185,000
-47.3%
740,7400.0%0.39%
-48.3%
CVRX  CVRx, Inc.$3,531,000
-40.9%
213,4790.0%0.33%
-41.9%
IBRX  ImmunityBio, Inc.$3,270,000
-31.8%
335,7090.0%0.31%
-33.0%
EB  Eventbrite, Inc.$2,006,000
-0.4%
106,0640.0%0.19%
-2.6%
LOV  Spark Networks SEsponsored adr$1,759,000
-32.2%
501,0260.0%0.16%
-33.5%
YEXT  Yext, Inc.$1,385,000
-15.8%
115,1470.0%0.13%
-17.2%
ROOT  Root, Inc.$1,077,000
-51.3%
204,3140.0%0.10%
-52.1%
DCT  Duck Creek Technologies, Inc.$642,000
+1.7%
14,5080.0%0.06%0.0%
PACB  Pacific Biosciences of California, Inc.$600,000
-26.9%
23,4840.0%0.06%
-28.2%
CSLT  Castlight Health, Inc.$548,000
-40.3%
349,0700.0%0.05%
-42.0%
CTMX  Cytomx Therapeutics, Inc.$403,000
-19.6%
79,1930.0%0.04%
-20.8%
MCRB  Seres Therapeutics, Inc.$344,000
-70.8%
49,3630.0%0.03%
-71.7%
ALGS  Aligos Therapeutics, Inc.$291,000
-24.0%
18,7830.0%0.03%
-27.0%
TRVN  Trevena, Inc.$288,000
-27.1%
233,8500.0%0.03%
-28.9%
PMVP  PMV Pharmaceuticals$229,000
-12.9%
7,6920.0%0.02%
-12.0%
YMTX  Yumanity$227,000
-11.7%
22,0300.0%0.02%
-16.0%
EPZM  Epizyme, Inc.$126,000
-38.5%
24,6860.0%0.01%
-40.0%
NXTC  NextCure, Inc.$68,000
-16.0%
10,0440.0%0.01%
-25.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wayfair, Inc.25Q3 202383.5%
Trevena, Inc.25Q4 20211.2%
Finjan Holdings, Inc.23Q2 202018.5%
Zuora, Inc.21Q3 20233.4%
Evelo Biosciences, Inc.20Q1 202326.3%
CytomX Therpeutics, Inc.19Q4 20212.3%
LendingClub Corp.18Q3 201911.9%
Rubius Therapeutics, Inc.18Q4 202221.4%
Solarwinds Corp.17Q4 202260.4%
Axcella Health, Inc.17Q2 20236.7%

View HARBOURVEST PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HARBOURVEST PARTNERS LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SolarWinds CorpFebruary 14, 20223,719,6002.3%
N-able, Inc.December 20, 20213,719,6002.1%
OncoMed Pharmaceuticals IncFebruary 14, 20191,901,1064.9%
Wayfair Inc.February 16, 20162,115,2964.6%
ENVIVIO INCFebruary 13, 20133,639,93913.5%
NETWORK ENGINES INCSold outFebruary 13, 201300.0%
VOCALTEC COMMUNICATIONS LTDAugust 06, 2010243,6892.1%
CERAGON NETWORKS LTDSold outJuly 26, 200700.0%
VISTAPRINT LTDSold outFebruary 14, 200700.0%
VOCALTEC COMMUNICATIONS LTDMay 26, 20061,218,44424.4%

View HARBOURVEST PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
40-APP2024-04-24
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR/A2022-05-26
13F-HR2022-05-13

View HARBOURVEST PARTNERS LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1064627000.0 != 1064630000.0)

Export HARBOURVEST PARTNERS LLC's holdings